JenaValve Ya Nada Kari Moore a matsayin Babban Jami'in Kuɗi

IRVINE, Calif., Mayu 17, 2022 (GLOBE NEWSWIRE) - JenaValve Technology, Inc. ("JenaValve ko "Kamfanin"), mai haɓakawa kuma mai ƙira na tsarin maye gurbin bawul ɗin bawul (TAVR), a yau ya sanar da nada na Kari Moore a matsayin Babban Jami'in Harkokin Kudade na kamfanin ya fara aiki a ranar 10 ga Mayu, 2022. "Muna farin cikin maraba da Kari zuwa tawagar JenaValve," in ji JenaValve Shugaba John Kilcoyne." kiwon lafiya masana'antu. Babban ilimin Kari da ƙwarewar masana'antu zai taimaka mana mu ci gaba da aiwatar da dabarunmu na asibiti da haɓaka Trilogy ɗinmu don magance cutar bawul ɗin bawul ɗin ® Ƙoƙarin Kasuwanci don Tsarin Zuciya. Ms. Moore ta shiga JenaValve bayan ta yi aiki a matsayin Babban Jami'in Akanta na Kamfanin Envista Holdings Corporation, wani kamfani na haƙori na duniya, inda ta kasance mai alhakin kula da lissafin kuɗi, kuɗi da ayyukan ayyuka na duniya. Kafin shiga Envista Holdings Corporation, Ms. Moore ita ce Shugaba. Jami'in Accounting na Kamfanin Kula da Lafiya na Applied, kamfanin na'urar na'urar likitanci na duniya da ke samar da fasaha da mafita don cutarwa da kuma tiyata gabaɗaya.Ms. Moore ta fara ayyukanta ne a PricewaterhouseCoopers, inda ta yi aiki a matsayin abokin aikin tantancewa, ta kware a masana'antar kimiyyar rayuwa. A cikin shekaru 20 da ta yi aiki, Ms. Moore ta dauki kamfanoni da yawa a bainar jama'a tare da taimaka musu wajen saye da sayarwa da bayar da bashi.Kari ya rike. BA a Gudanar da Kasuwanci daga Jami'ar Kudancin California kuma CPA ce a jihar California. "Na yi farin cikin shiga JenaValve a irin wannan mawuyacin lokaci," in ji Ms. Moore. "Na yi farin cikin yin aiki tare da dukan ƙungiyar JenaValve yayin da muke ci gaba da aiwatar da dabarun haɓaka da ƙimar mu yayin inganta rayuwar marasa lafiya." Game da JenaValve JenaValve Technology, Inc., hedkwatarsa ​​a Irvine, California, tare da wurare a Leeds, UK da Munich, Jamus, tasowa da kuma samar da transcatheter aortic valve maye gurbin (TAVR) tsarin don kula da marasa lafiya da aortic valve cuta.JenaValve yana goyon bayan ta Bain Capital Life Sciences da Cormorant Asset Management, da masu zuba jari na Turai da Asiya ciki har da Andera Partners, Gimv (Euronext: GIMB), Legend Capital, NeoMed Management, RMM, Valiance Life Sciences, VI Partners da Peijia Medical Limited (HKEx: 9996) . Amurka: Hankali - Kayan Aikin Bincike.An ƙuntata ta dokar tarayya (ko Amurka) don amfani da bincike kawai.